Moving Medicine Forward

CTI Clinical Trials
  • ٤٫٨ (١٧)
  • علوم حياة
  • يتم التحديث شهريًا

CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.

  1. MMF Rewind | CTI's Next Chapter: A Conversation with Jon Koch and Brian Lawrence

    قبل ٤ أيام

    MMF Rewind | CTI's Next Chapter: A Conversation with Jon Koch and Brian Lawrence

    This week, we're revisiting a previous conversation with Jon Koch, CEO, and Brian Lawrence, CFO and President, as they share their perspective on what’s next for CTI as the organization enters a new phase of growth. They reflect on CTI’s legacy of partnership and execution while outlining how they plan to expand its impact across complex clinical trials. From scaling capabilities and investing in talent to strengthening operational discipline and embracing data-driven decision-making, Jon and Brian offer an inside look at how leadership alignment is shaping strategy. They also explore the evolving demands of the clinical research industry, from the need for predictability and site support to the practical application of technology and AI. At its core, this conversation is about balancing growth with purpose: delivering for sponsors, strengthening teams, and ultimately improving outcomes for patients. 00:36 CTI Rewind: Revisiting CTI's leadership transition and future vision00:58 Expanding CTI's reach in complex and advanced therapy trials02:23 Disciplined growth strategy and sustainable global expansion04:38 CTI's legacy of care, credibility, and partnership06:14 Driving performance through metrics and accountability09:03 Leadership alignment and partnership in action12:13 Talent development, infrastructure, and AI enablement14:14 Positioning CTI for continued growth in complex trials17:12 Key industry trends: predictability, sites, and technology20:40 Sustaining culture and employee experience22:08 Long-term vision: scale, impact, and global presence25:15 Closing takeaways: quality, people, and execution

    ٢٦ د
  2. Small Wins, Big Impact: Lessons from Pediatric Oncology

    ٢٥ يونيو

    Small Wins, Big Impact: Lessons from Pediatric Oncology

    What does it take to design clinical trials that truly put patients first—especially when those patients are children? In this episode of Moving Medicine Forward, Dr. Radhika Peddinti, Medical Director at CTI, discusses her journey from pediatric hematology/oncology at the bedside to shaping clinical research at a global scale. Drawing on more than two decades of experience caring for children and their families, Dr. Pennant shares how those deeply human moments continue to influence how she approaches trial design today. From the emotional realities of pediatric oncology to the promise of gene therapies and targeted treatments, this conversation highlights the balance between scientific rigor and compassion—and why both are essential to advancing medicine. Together, they discuss how clinical trials can be designed to reflect real patient lives, the evolving landscape of rare disease research, and the leadership perspective required to make decisions that impact patients far beyond the clinic. If you're interested in the future of pediatric research, patient centered innovation, and what it truly means to move medicine forward, this episode is for you.   00:37 Meet Dr. Peddinti | Background in pediatric hematology/oncology and transition to CTI. 01:17 Finding Her Path | From training in India to a career shaped by patient and family experiences. 03:37 From Bedside to Research | Shifting focus to impact patients at a broader scale. 04:00 The Reality of Pediatric Oncology | Challenges, resilience, and redefining normal for children and families. 05:39 Expanding Impact Through Trials | Sickle cell research and the move into clinical development. 07:33 Designing with Patients in Mind | Bringing real-life patient needs into clinical trial design. 08:58 Balancing Science & Compassion | Why rigor and humanity are both critical to successful trials. 09:30 Leadership Lessons | Showing up with honesty, empathy, and adaptability. 10:47 The Future of Medicine | Breakthroughs in targeted therapies, gene therapy, and cure-focused research. 13:15 Advice for Clinicians | You don’t need to check every box—your experience matters.

    ١٥ د
  3. Biorepositories in Action: Protecting the Integrity of Every Sample

    ١٧ يونيو

    Biorepositories in Action: Protecting the Integrity of Every Sample

    In this episode, we’re joined by Rafael Miñana Prieto, Senior Manager of Operations for Laboratory Services at CTI, who oversees global biorepository operations across the U.S. and Europe. He walks through the full specimen lifecycle—from kit design and sample collection to storage, retrieval, and delivery—and explains why biological specimens are the foundation of clinical research. Rafael shares how consistent, end-to-end management, global standardization, and integrated laboratory services help protect data integrity, reduce risk, and improve outcomes across trials. He also highlights how small upstream decisions can impact downstream results, along with the operational challenges and evolving trends shaping modern biorepository services.   01:26 Rafael’s role and the end-to-end specimen lifecycle 02:15 Why sample integrity underpins clinical evidence and patient impact 03:26 Lifecycle complexity and global logistics challenges 04:16 Standardization, monitoring, and risk reduction strategies 05:32 Coordinating retrieval and global shipment 06:31 Upstream decisions (kit design, instructions) shaping outcomes 07:23 Integrated lab services and reduced fragmentation 07:59 Scaling challenges and pre-analytical gaps 09:24 Key trends: complexity, globalization, and data-driven operations 10:07 CAP accreditation and delivering consistent global standards

    ١٢ د
  4. Engineering Organs: The Science Powering Xenotransplantation

    ١١ يونيو

    Engineering Organs: The Science Powering Xenotransplantation

    In this episode of Moving Medicine Forward, Dr. Robert Fisher—one of the pioneers of modern transplant surgery—explores the rapidly advancing field of xenotransplantation and why it may represent a true turning point in medicine. From CRISPR-driven genetic engineering to breakthroughs in immunosuppression and scalable organ production, Dr. Fisher breaks down how decades of research are converging to make cross-species organ transplants a clinical reality. The conversation also dives into what this means for patients, how it could transform transplant access, and the critical role of rigorous, collaborative clinical research in translating breakthrough science into real-world care. 01:23 Dr. Fisher’s path into transplant surgery 03:05 Why xenotransplantation is reaching a turning point (CRISPR + immunosuppression) 04:47 Advances enabling scalability, safety, and compatibility 08:32 Ethics, risks, and clearing misconceptions 10:27 Real-world patient impact and clinical considerations 13:10 Logistics, coordination, and clinical execution 15:49 New immunosuppression strategies driving success 17:44 Collaboration, ethics, and managing risk 20:49 Eliminating waitlists: expanding access to transplant 22:54 Milestones toward adoption and future outlook

    ٢٤ د
  5. Adapting to Industry Rebound: The Next Phase of Clinical Trials

    ٣ يونيو

    Adapting to Industry Rebound: The Next Phase of Clinical Trials

    What does a recovering clinical research market actually look like in 2026? In this episode, Joel White, Owner of Market Cap Consulting, and Ryan Gifford, Vice President, Global Laboratory Services, Business Development & Client Management at CTI, join us to unpack the state of the industry—from the rebound in biotech funding to the growing importance of execution, site relationships, and smarter trial design. We explore how increasing complexity is shaping partnerships, how labs and decentralized models are evolving, and what it will take to keep trials on track. Looking ahead, the conversation offers a practical perspective on what the next 12–18 months could bring.   01:00 Guest backgrounds: Joel White (Market Cap Consulting) and Ryan Gifford (CTI) 02:45 Market recovery and funding trends 05:15 Trial success: early collaboration and site relationships 08:15 Funding challenges and execution impacts 10:30 Reducing site burden through lab operations and logistics 14:15 Decentralized trials and patient experience 16:25 Regulatory shifts, AI, and growing data complexity 19:30 Future outlook: partnerships and global trial expansion 23:30 Key takeaways and rapid-fire insights

    ٢٨ د
  6. MMF Rewind | Life After Transplant, Reimagined: Enduring Hearts & Pediatric Research

    ٢٧ مايو

    MMF Rewind | Life After Transplant, Reimagined: Enduring Hearts & Pediatric Research

    In this MMF Rewind, we’re bringing back an important conversation with Lynda Lee Smith—one that shines a light on the ongoing challenges transplant families face and the critical role of research in improving outcomes. Lynda Lee Smith, CEO of Enduring Hearts, is featured on the Moving Medicine Forward Podcast to discuss the mission and impact of the nation’s only nonprofit dedicated to funding pediatric heart transplant research. In this conversation, Lynda addresses the challenges transplant families face and how research is improving outcomes and quality of life. Listen now and consider donating to Enduring Hearts here. 00:55 The mission behind the only organization dedicated exclusively to pediatric heart transplant research. 01:19 How Lynda found Enduring Hearts and its mission-driven work. 02:45 The personal story that exposed a major research gap in pediatric heart transplantation. 03:50 Why heart transplants are lifesaving, but not a cure. 04:22 More on home blood tests and their role in reducing invasive biopsies and improving quality of life. 05:39 Why Enduring Hearts focuses on making one transplant last a lifetime. 07:06 How Enduring Hearts supports bold research ideas before larger funders step in. 09:40 The unique challenges teenagers face after transplant and how research helps. 12:05 Addressing the financial, emotional, and logistical burdens families face. 15:21 Programs that connect families navigating life after pediatric transplant. 15:49 Enduring Hearts’ innovative approach to engaging a new generation through gaming. 18:04 The move toward DNA informed, individualized treatment plans. 19:19 What real success looks like for pediatric heart transplant patients. 21:08 Stories of resilience, progress, and hope for the future.

    ٢٢ د
  7. CTI’s Next Chapter: A Conversation with Jon Koch and Brian Lawrence

    ١٩ مايو

    CTI’s Next Chapter: A Conversation with Jon Koch and Brian Lawrence

    In this episode, Jon Koch, CEO, and Brian Lawrence, CFO and President, share their perspective on what’s next for CTI as the organization enters a new phase of growth. They reflect on CTI’s legacy of partnership and execution while outlining how they plan to expand its impact across complex clinical trials. From scaling capabilities and investing in talent to strengthening operational discipline and embracing data driven decision-making, Jon and Brian offer an inside look at how leadership alignment is shaping strategy. They also explore the evolving demands of the clinical research industry, from the need for predictability and site support to the practical application of technology and AI. At its core, this conversation is about balancing growth with purpose: delivering for sponsors, strengthening teams, and ultimately improving outcomes for patients.   00:35 CTI leadership transition and future focus01:23 Expanding reach in complex and advanced therapy trials02:48 Disciplined growth strategy and global expansion05:03 CTI’s legacy of care, credibility, and partnership06:39 Driving performance through metrics and accountability09:28 Leadership alignment and partnership in action12:38 Talent development, infrastructure, and AI enablement14:38 Positioning for growth in complex trials17:37 Key industry trends: predictability, sites, and tech21:05 Sustaining culture and employee experience22:33 Long-term vision: scale, impact, and global presence25:39 Closing takeaways: quality, people, and execution

    ٢٦ د
  8. Practicing Medicine, Leading Research: A Physician’s Transition to Clinical Trials

    ١٣ مايو

    Practicing Medicine, Leading Research: A Physician’s Transition to Clinical Trials

    What does effective medical leadership look like in today’s complex research environment? In this episode of Moving Medicine Forward, Dr. Sliman discusses his path from patient care to clinical research leadership. Drawing on decades of experience, Dr. Sliman shares lessons on staying patient‑centered, navigating regulatory realities, and leading teams within evolving healthcare systems—offering practical insights for physicians and researchers shaping the future of clinical development. 00:36 Dr. Sliman’s background spanning clinical care, research, and medical leadership. 01:10 Pop culture influences (MASH*, Star Trek) and family roots in healthcare that sparked Dr. Sliman’s interest in becoming a physician. 03:42 Early research experiences and witnessing healthcare disparities in developing countries. 05:05 Why individual patient journeys still matter—even as studies scale and become more complex. 06:55 Leading within financial, regulatory, and operational constraints while staying patient‑centered. 08:32 Lessons on navigating rules, expanding boundaries, and achieving outcomes through collaboration. 10:36 Building infrastructure, sharing institutional knowledge, and avoiding repeated mistakes in clinical development. 11:53 Endpoint strategy, patient population selection, and negotiating within regulatory frameworks. 13:19 Understanding evolving regulatory expectations and operating effectively within them. 14:26 Why learning the system—regulatory, operational, and corporate—is essential. 16:02 Balancing passion for patient care with research experience and real‑world trial exposure. 19:27 Reflections on medicine, leadership, and the importance of staying connected to patient impact.

    ٢٠ د
مشاهدة الكل (٦٣)

مقطع ترويجي

٤٫٨
من ٥
‫١٧ من التقييمات‬

حول

CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.

المعلومات

  • صناع العمل
    CTI Clinical Trials
  • سنوات النشاط
    ٢٠٢٤ - ٢٠٢٦
  • الحلقات
    ٦٣
  • التقييم
    ملائم
  • حقوق النشر
    © CTI Clinical Trials
  • موقع البرنامج على الويب
    Moving Medicine Forward

قد يعجبك أيضًا